Eptinezumab

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

China HeadAche DIsorders RegiStry

Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)

Eptinezumab for Chronic Headache in Idiopathic Intracranial Hypertension

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

Facilitators and Barriers to Eptinezumab Administration in Thailand

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine

Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)

Migraine Medication Effects on Urinary Symptoms

A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy

Eptinezumab in Participants With Episodic Cluster Headache

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)

Real World Effectiveness of Eptinezumab in Participants With Migraine

Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context

Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.

A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab